Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Sidransky

Showing results (11-20 of 389) with videos related to

Pageof 39
Sort By:
Cell Cycle (Georgetown, Tex.)|August 27, 2005
DeltaNp63alpha levels correlate with clinical tumor response to cisplatinRachel Zangen, Edward Ratovitski, David Sidransky
Clinical Chemistry|December 18, 2019
Tissue and Cell-Free DNA-Based Epigenomic Approaches for Cancer DetectionAlessandro Leal, David Sidransky, Mariana Brait
Nature Genetics|April 4, 2023
Unexpected heterogeneity in oropharyngeal squamous cell tumorsDavid J Peace, Evgeny Izumchenko, David Sidransky
Methods in Molecular Biology (Clifton, N.J.)|May 17, 2002
Identification of mtDNA mutations in human cancerShuji Nomoto, Montserrant Sanchez-Cespedes, David Sidransky
Cancer Metastasis Reviews|February 6, 2010
DNA methylation markers in colorectal cancerMyoung Sook Kim, Juna Lee, David Sidransky
Nature Reviews. Cancer|October 23, 2003
Proteomic analysis of cancer-cell mitochondriaMukesh Verma, Jacob Kagan, David Sidransky, et al.
Cell Cycle (Georgetown, Tex.)|November 20, 2010
Regulation of ΔNp63α by NFκΒTanusree Sen, Xiaofei Chang, David Sidransky, et al.
Cell Cycle (Georgetown, Tex.)|December 18, 2009
Yes-associated protein 1 regulates the stability of DeltaNp63alphaAditi Chatterjee, Tanusree Sen, Xiaofei Chang, et al.
Oncogene|October 16, 2002
Molecular detection approaches for smoking associated tumorsYing Chuan Hu, David Sidransky, Steven A Ahrendt
Cancer Investigation|November 25, 2005
Ribonucleases as a novel pro-apoptotic anticancer strategy: review of the preclinical and clinical data for ranpirnaseJohn Costanzi, David Sidransky, Ami Navon, et al.
Pageof 39

Showing results (11-20 of 389) with videos related to

Sort By:
Pageof 39
Cell Cycle (Georgetown, Tex.)|August 27, 2005
DeltaNp63alpha levels correlate with clinical tumor response to cisplatinRachel Zangen, Edward Ratovitski, David Sidransky
Clinical Chemistry|December 18, 2019
Tissue and Cell-Free DNA-Based Epigenomic Approaches for Cancer DetectionAlessandro Leal, David Sidransky, Mariana Brait
Nature Genetics|April 4, 2023
Unexpected heterogeneity in oropharyngeal squamous cell tumorsDavid J Peace, Evgeny Izumchenko, David Sidransky
Methods in Molecular Biology (Clifton, N.J.)|May 17, 2002
Identification of mtDNA mutations in human cancerShuji Nomoto, Montserrant Sanchez-Cespedes, David Sidransky
Cancer Metastasis Reviews|February 6, 2010
DNA methylation markers in colorectal cancerMyoung Sook Kim, Juna Lee, David Sidransky
Nature Reviews. Cancer|October 23, 2003
Proteomic analysis of cancer-cell mitochondriaMukesh Verma, Jacob Kagan, David Sidransky, et al.
Cell Cycle (Georgetown, Tex.)|November 20, 2010
Regulation of ΔNp63α by NFκΒTanusree Sen, Xiaofei Chang, David Sidransky, et al.
Cell Cycle (Georgetown, Tex.)|December 18, 2009
Yes-associated protein 1 regulates the stability of DeltaNp63alphaAditi Chatterjee, Tanusree Sen, Xiaofei Chang, et al.
Oncogene|October 16, 2002
Molecular detection approaches for smoking associated tumorsYing Chuan Hu, David Sidransky, Steven A Ahrendt
Cancer Investigation|November 25, 2005
Ribonucleases as a novel pro-apoptotic anticancer strategy: review of the preclinical and clinical data for ranpirnaseJohn Costanzi, David Sidransky, Ami Navon, et al.
Pageof 39